Nasser Catheter Inc. is developing a novel float-controlled urinary catheter that solves two critical challenges in bladder cancer treatment: short dwell time of intravesical therapies and inconsistent bladder filling during radiation. By draining only excess urine, the device prolongs BCG and chemotherapy exposure from about 1 hour to 3–4 hours, while also enabling tumor-focused, bladder-sparing precision in radiotherapy.
